In this episode of the Lupus Foundation of America's The Expert Series podcast, we focus on GLP-1 Therapies and Lupus. Our guest, Dr. Paul Hoover, discusses what we know about obesity and its impact on people living with lupus, how GLP-1 therapies work, and what researchers are learning about their potential role in lupus and related health outcomes.


Sign up to receive emails from the Lupus Foundation of America (LFA) when new episodes are published: https://support.lupus.org/site/SPageNavigator/email_subscribe_expert_series.html


Episode Takeaways:

  • Why obesity is an important consideration for people living with lupus
  • What we currently understand about the relationship between obesity and lupus outcomes
  • How GLP-1 therapies work and why researchers are interested in their potential role in lupus
  • What is known—and what remains unknown—about the potential effects of GLP-1 therapies beyond weight loss, including blood sugar and kidney health
  • What people living with lupus should know when considering GLP-1 therapies and discussing them with their healthcare team


Related Resources:

  • Ask a Lupus Health Educator (LFA): https://www.lupus.org/care-support/ask-a-health-educator
  • Find Support Near You (LFA): https://www.lupus.org/resources/find-support-near-you
  • National Resource Center on Lupus (LFA): https://www.lupus.org/resources
  • The Expert Series (LFA): https://www.lupus.org/resources/lupus-the-expert-series
  • Research Accelerated by You (LFA): https://www.lupus.org/research/enroll-in-a-lupus-registry


Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör Lupus Foundation of America. Innehållet i podden är skapat av Lupus Foundation of America och inte av, eller tillsammans med, Poddtoppen.